๐ฌDeep Research
HSIC โ Henry Schein Inc ยท catalysts, narrative & risks
Current snapshot (as of early October 2026)
Henry Schein (HSIC, Nasdaq, S&P 500) is a FORTUNE 500 healthcare distributor serving office-based dental and medical practitioners, laboratories, and clinics worldwide [14], [17]. As of October 2, 2026, the stock closed at ~$84.88 with a market cap of ~$9.46B [14], [16]. Key metrics: trailing P/E ~24.75, forward P/E ~15.01, EPS (TTM) ~$3.43, no dividend, ~6.85% short interest (~8.3 days to cover), and ~96.6% institutional ownership [15], [19]. The 52-week range is $61.95โ$92.18 [14].
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ